Detalhe da pesquisa
1.
JAK-STAT signaling maintains homeostasis in T cells and macrophages.
Nat Immunol
; 25(5): 847-859, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658806
2.
Dynamic control of gene expression by ISGF3 and IRF1 during IFNß and IFNγ signaling.
EMBO J
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658796
3.
Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions.
Nat Immunol
; 17(12): 1361-1372, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27798618
4.
STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling.
Nat Immunol
; 15(2): 168-76, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24413774
5.
Efficacy and safety of everolimus plus exemestane in patients with hormone receptor-positive, HER-2-negative advanced breast cancer: Results from the open-label, multicentre, non-interventional BRAWO study.
Int J Cancer
; 155(1): 128-138, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447007
6.
Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer: Real-world data from the noninterventional TACTIC study in Germany.
Int J Cancer
; 153(6): 1227-1240, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260368
7.
Plasma apolipoprotein M predicts overall survival in metastatic breast cancer patients.
Breast Cancer Res Treat
; 201(3): 571-576, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37490173
8.
Breast Density and Breast Cancer Screening with Digital Breast Tomosynthesis: A TOSYMA Trial Subanalysis.
Radiology
; 306(2): e221006, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194110
9.
Digital Breast Tomosynthesis versus Digital Mammography for Detection of Early-Stage Cancers Stratified by Grade: A TOSYMA Subanalysis.
Radiology
; 309(3): e231533, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051184
10.
Listeria monocytogenes infection rewires host metabolism with regulatory input from type I interferons.
PLoS Pathog
; 17(7): e1009697, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237114
11.
The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice.
BMC Cancer
; 23(1): 543, 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312086
12.
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3 / AIO KRK-0306.
Eur Radiol
; 33(2): 1174-1184, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35976398
13.
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Int J Cancer
; 150(1): 112-123, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431518
14.
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
Br J Cancer
; 127(5): 836-843, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637412
15.
Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation.
FASEB J
; 35(10): e21892, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34569651
16.
Serine Phosphorylation of the STAT1 Transactivation Domain Promotes Autoreactive B Cell and Systemic Autoimmunity Development.
J Immunol
; 204(10): 2641-2650, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32253245
17.
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Int J Cancer
; 149(11): 1935-1943, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310714
18.
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111).
Int J Cancer
; 148(6): 1428-1437, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32930387
19.
FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial.
Br J Cancer
; 124(3): 587-594, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154570
20.
The RNA helicase DDX3X is an essential mediator of innate antimicrobial immunity.
PLoS Pathog
; 14(11): e1007397, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30475900